+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mycoplasma Testing Market - Global Forecast 2025-2030- Product Image
Mycoplasma Testing Market - Global Forecast 2025-2030- Product Image
Sale

Mycoplasma Testing Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674108
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Mycoplasma Testing Market is experiencing rapid evolution driven by increased demands for biological quality assurance, technological advancements, and shifting global regulatory standards. Senior leaders across biopharma, diagnostics, and research sectors are seeking strategic insights to ensure robust contamination controls and optimize market positioning.

Market Snapshot: Mycoplasma Testing Market Growth and Drivers

The mycoplasma testing market grew from USD 1.08 billion in 2024 to USD 1.17 billion in 2025. It is expected to continue expanding at a CAGR of 8.34%, reaching USD 1.75 billion by 2030. This growth reflects intensifying efforts to eliminate the pervasive risks mycoplasma pose throughout cell-based research, biopharma manufacturing, and clinical diagnostics.

Scope & Segmentation

This report offers comprehensive segmentation and regional analysis, focusing on advancing technologies and industry trends shaping the market landscape.

  • Test Types: Culture methods, PCR assays, and serological assays each address specific sensitivity, speed, and workflow needs for diverse laboratory environments.
  • Sample Types: Blood, throat swab, and urine specimens, with validation and matrix considerations unique to each sample source.
  • End Users: Diagnostic laboratories, hospitals, pharmaceutical companies, and research institutes, each requiring tailored workflows and compliance standards.
  • Products: Kits for ready-to-use requirements, reagents for customized testing, and services supporting consulting, installation, and maintenance.
  • Applications: Clinical diagnostics (confirmatory testing, routine screening), pharmaceutical applications (drug screening, vaccine research), and research settings (drug development, epidemiology).
  • Pathogen Types: Segmented between Mycoplasma genitalium and Mycoplasma pneumoniae to address clinical and research priorities.
  • Regions Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including major and emerging markets), and Asia-Pacific (key economies and research hubs).

Key Takeaways

  • Growing regulatory focus is pushing laboratories and manufacturers toward validated, automated, and high-throughput mycoplasma detection workflows, reinforcing audit readiness and consistent quality outcomes.
  • The adoption of integrated platforms—incorporating test kits, reagents, data analytics, and support services—is redefining the competitive landscape by offering scalable, end-to-end solutions.
  • Strategic partnerships and alliances are emerging between assay developers, CROs, and regional distributors to serve fast-evolving local requirements and strengthen market penetration.
  • Increasing emphasis on digitalization enhances workflow efficiency and traceability, while continuous investment in automated detection reduces operational risk and manual error.
  • Pathogen-specific testing enables institutions to address targeted research objectives, while product and service diversification allows vendors to accommodate a broad spectrum of user needs.

Tariff Impact and Supply Chain Strategy

Recent United States tariff measures have introduced new complexities to global mycoplasma testing supply chains, affecting reagent and instrumentation costs, sourcing strategies, and lead times. While some manufacturers turn to regional production to stabilize availability and pricing, organizations across the value chain are now prioritizing supply chain resilience by diversifying suppliers, entering long-term agreements, or increasing in-house production, ultimately strengthening operational continuity amidst ongoing trade uncertainties.

Methodology & Data Sources

Market insights derive from a combination of primary research—interviews with industry executives, laboratory managers, and technical experts—and secondary research spanning regulatory documents, peer-reviewed literature, patent records, and marketplace analyses. Analytical frameworks include supply chain risk assessment, technology readiness evaluation, and scenario planning to assess policy impacts. Industry advisors validate findings to ensure actionable, up-to-date intelligence.

Why This Report Matters

  • Enables senior decision-makers to benchmark emerging technology adoption and strengthen their quality assurance strategies.
  • Equips commercial leaders with segmentation and trend analysis to inform portfolio development, partnership choices, and go-to-market planning.
  • Supports risk mitigation and long-range planning with objective analysis of global supply chain dynamics, tariff effects, and regulatory trends.

Conclusion

This report provides a strategic foundation for navigating the evolving mycoplasma testing market, offering essential insights for leaders driving innovation, ensuring compliance, and building resilient operations. Use these findings to align investments, partnerships, and processes with future industry demands.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of real-time PCR assays into routine mycoplasma testing workflows to improve speed and accuracy
5.2. Emergence of digital PCR technology for ultra-sensitive detection of low-level mycoplasma contamination in bioprocessing
5.3. Shift towards automation and high-throughput mycoplasma detection platforms in vaccine manufacturing facilities
5.4. Regulatory emphasis on comprehensive sterility testing driving demand for advanced mycoplasma detection kits
5.5. Growing adoption of multiplex assays enabling simultaneous detection of multiple mycoplasma species in cell therapy products
5.6. Development of point-of-care mycoplasma testing devices for rapid contamination monitoring in research labs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Mycoplasma Testing Market, by Test Type
8.1. Introduction
8.2. Culture Methods
8.3. Pcr
8.4. Serological Assays
9. Mycoplasma Testing Market, by Sample Type
9.1. Introduction
9.2. Blood
9.3. Throat Swab
9.4. Urine
10. Mycoplasma Testing Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals
10.4. Pharmaceutical Companies
10.5. Research Institutes
11. Mycoplasma Testing Market, by Product
11.1. Introduction
11.2. Kits
11.3. Reagents
11.4. Services
11.4.1. Consulting
11.4.2. Installation And Maintenance
12. Mycoplasma Testing Market, by Application
12.1. Introduction
12.2. Clinical Diagnostics
12.2.1. Confirmatory Testing
12.2.2. Routine Screening
12.3. Pharmaceutical
12.3.1. Drug Screening
12.3.2. Vaccine Research
12.4. Research
12.4.1. Drug Development
12.4.2. Epidemiology
13. Mycoplasma Testing Market, by Pathogen Type
13.1. Introduction
13.2. Mycoplasma Genitalium
13.3. Mycoplasma Pneumoniae
14. Americas Mycoplasma Testing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Mycoplasma Testing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Mycoplasma Testing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Merck KGaA
17.3.3. Lonza Group AG
17.3.4. Charles River Laboratories International Inc.
17.3.5. Bio-Rad Laboratories Inc.
17.3.6. Danaher Corporation
17.3.7. Roche Holding AG
17.3.8. Sartorius AG
17.3.9. Promega Corporation
17.3.10. QIAGEN N.V.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. MYCOPLASMA TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MYCOPLASMA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. MYCOPLASMA TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. MYCOPLASMA TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. MYCOPLASMA TESTING MARKET: RESEARCHAI
FIGURE 28. MYCOPLASMA TESTING MARKET: RESEARCHSTATISTICS
FIGURE 29. MYCOPLASMA TESTING MARKET: RESEARCHCONTACTS
FIGURE 30. MYCOPLASMA TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MYCOPLASMA TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MYCOPLASMA TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MYCOPLASMA TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CULTURE METHODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CULTURE METHODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SEROLOGICAL ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SEROLOGICAL ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY THROAT SWAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY THROAT SWAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CONSULTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CONSULTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY INSTALLATION AND MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY INSTALLATION AND MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CONFIRMATORY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CONFIRMATORY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ROUTINE SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ROUTINE SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DRUG SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DRUG SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY VACCINE RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY VACCINE RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY EPIDEMIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY EPIDEMIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY MYCOPLASMA GENITALIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY MYCOPLASMA GENITALIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY MYCOPLASMA PNEUMONIAE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY MYCOPLASMA PNEUMONIAE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 125. CANADA MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 126. CANADA MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 127. CANADA MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 128. CANADA MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 129. CANADA MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. CANADA MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. CANADA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 132. CANADA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 133. CANADA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 134. CANADA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 135. CANADA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. CANADA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. CANADA MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 138. CANADA MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 139. CANADA MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 140. CANADA MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 141. CANADA MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 142. CANADA MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 143. CANADA MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 144. CANADA MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 152. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 153. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 154. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 155. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 160. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 161. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 162. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 163. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 248. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 249. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 250. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 251. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 254. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 255. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 256. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 257. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 260. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 262. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 263. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 264. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 265. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 266. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 267. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 268. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 269. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 270. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 271. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 274. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 275. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 276. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 277. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 280. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 281. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 282. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 283. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 284. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 285. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 286. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 307. ITALY MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 308. ITALY MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 309. ITALY MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 310. ITALY MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 311. ITALY MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. ITALY MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. ITALY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 314. ITALY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 315. ITALY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 316. ITALY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 317. ITALY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. ITALY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. ITALY MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 320. ITALY MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 321. ITALY MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 322. ITALY MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 323. ITALY MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 324. ITALY MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 325. ITALY MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 326. ITALY MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 327. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 328. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 329. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 330. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 331. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 334. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 335. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 336. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 337. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 338. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 339. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 340. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 341. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 342. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 343. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 344. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 345. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 346. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 347. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 348. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 349. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY SAMPLE TYP

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Mycoplasma Testing market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Lonza Group AG
  • Charles River Laboratories International Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Roche Holding AG
  • Sartorius AG
  • Promega Corporation
  • QIAGEN N.V.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.17 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.75 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Mycoplasma Testing Market Report 2025 - Product Image

Mycoplasma Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Mycoplasma Diagnostics - Global Strategic Business Report - Product Image

Mycoplasma Diagnostics - Global Strategic Business Report

  • Report
  • 384 Pages
  • Global
From
Mycoplasma Testing - Global Strategic Business Report - Product Image

Mycoplasma Testing - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Mycoplasma Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Mycoplasma Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
2024-2029 Global Mycoplasma Testing Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities - Product Image

2024-2029 Global Mycoplasma Testing Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • Report
  • Europe, Global, Japan, ... Europe, Global, Japan, United States
From

About the Mycoplasma Test Market

The Mycoplasma Test market is a segment of the Infectious Disease Testing market. Mycoplasma testing is used to detect the presence of mycoplasma bacteria, which can cause a variety of diseases in humans and animals. Mycoplasma testing is used to diagnose and monitor the progression of mycoplasma infections, as well as to monitor the effectiveness of treatment. Mycoplasma testing is typically performed using a variety of methods, including culture, PCR, and serology. Mycoplasma testing is used in a variety of settings, including clinical laboratories, research laboratories, and veterinary laboratories. Mycoplasma testing is used to diagnose and monitor a variety of diseases, including pneumonia, bronchitis, and urinary tract infections. Some companies in the Mycoplasma Test market include Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, and Becton Dickinson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.